Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1985 1
1991 1
1999 1
2003 1
2005 2
2006 2
2007 3
2008 8
2009 7
2010 7
2011 9
2012 7
2013 10
2014 13
2015 10
2016 7
2017 4
2018 5
2019 4
2020 5
2021 6
2022 3
2023 6
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

112 results

Results by year

Filters applied: . Clear all
Page 1
Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir.
González-Cordón A, Assoumou L, Moyle G, Waters L, Johnson M, Domingo P, Fox J, Stellbrink HJ, Guaraldi G, Masiá M, Gompels M, De Wit S, Florence E, Esser S, Raffi F, Behrens G, Pozniak A, Gatell JM, Martínez E; NEAT 022 Study Group. González-Cordón A, et al. J Antimicrob Chemother. 2023 Sep 5;78(9):2361-2365. doi: 10.1093/jac/dkad247. J Antimicrob Chemother. 2023. PMID: 37539492
Clinical hematology in reptilian species.
Nardini G, Leopardi S, Bielli M. Nardini G, et al. Vet Clin North Am Exot Anim Pract. 2013 Jan;16(1):1-30. doi: 10.1016/j.cvex.2012.09.001. Vet Clin North Am Exot Anim Pract. 2013. PMID: 23347537 Review.
Evaluating immunological and inflammatory changes of treatment-experienced people living with HIV switching from first-line triple cART regimens to DTG/3TC vs. B/F/TAF: the DEBATE trial.
Cossarizza A, Cozzi-Lepri A, Mattioli M, Paolini A, Neroni A, De Biasi S, Tartaro DL, Borella R, Fidanza L, Gibellini L, Beghetto B, Roncaglia E, Nardini G, Milic J, Menozzi M, Cuomo G, Digaetano M, Orlando G, Borghi V, Guaraldi G, Mussini C. Cossarizza A, et al. Among authors: nardini g. Front Immunol. 2023 Oct 16;14:1279390. doi: 10.3389/fimmu.2023.1279390. eCollection 2023. Front Immunol. 2023. PMID: 37908359 Free PMC article. Clinical Trial.
Managing the relationship between quality and cost-effective burn care.
Stavrou D, Weissman O, Winkler E, Millet E, Nardini G, Tessone A, Zmora N, Mushin OP, Haik J. Stavrou D, et al. Among authors: nardini g. Burns. 2011 May;37(3):367-76. doi: 10.1016/j.burns.2010.10.006. Epub 2010 Dec 4. Burns. 2011. PMID: 21130580 Review.
The effect of mission duration on LISA science objectives.
Amaro Seoane P, Arca Sedda M, Babak S, Berry CPL, Berti E, Bertone G, Blas D, Bogdanović T, Bonetti M, Breivik K, Brito R, Caldwell R, Capelo PR, Caprini C, Cardoso V, Carson Z, Chen HY, Chua AJK, Dvorkin I, Haiman Z, Heisenberg L, Isi M, Karnesis N, Kavanagh BJ, Littenberg TB, Mangiagli A, Marcoccia P, Maselli A, Nardini G, Pani P, Peloso M, Pieroni M, Ricciardone A, Sesana A, Tamanini N, Toubiana A, Valiante R, Vretinaris S, Weir DJ, Yagi K, Zimmerman A. Amaro Seoane P, et al. Among authors: nardini g. Gen Relativ Gravit. 2022;54(1):3. doi: 10.1007/s10714-021-02889-x. Epub 2021 Dec 27. Gen Relativ Gravit. 2022. PMID: 35221342 Free PMC article.
Treatment Algorithm for Hyaluronic Acid-Related Complication Based on a Systematic Review of Case Reports, Case Series, and Clinical Experience.
Aviv U, Haik J, Weiss N, Berl A, Ofir H, Nardini G, Cleary M, Kornhaber R, Harats M. Aviv U, et al. Among authors: nardini g. Craniomaxillofac Trauma Reconstr. 2020 Dec;13(4):313-328. doi: 10.1177/1943387520952687. Epub 2020 Sep 1. Craniomaxillofac Trauma Reconstr. 2020. PMID: 33456703 Free PMC article. Review.
Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial.
Waters L, Assoumou L, González-Cordón A, Rusconi S, Domingo P, Gompels M, de Wit S, Raffi F, Stephan C, Masiá M, Rockstroh J, Katlama C, Behrens GMN, Moyle G, Johnson M, Fox J, Stellbrink HJ, Guaraldi G, Florence E, Esser S, Gatell JM, Pozniak A, Martínez E; NEAT 022 Study Group. Waters L, et al. Clin Infect Dis. 2023 Mar 4;76(5):861-870. doi: 10.1093/cid/ciac827. Clin Infect Dis. 2023. PMID: 36259527 Clinical Trial.
112 results